ArticleAmerican journal of cancer research2022

Bortezomib- and carfilzomib-resistant myeloma cells show increased activity of all three arms of the unfolded protein response.

Tadeusz Kubicki et al.PubMed ↗Full text ↗

No numbers read from the abstract.